UBS Maintains Neutral Rating for Universal Health Servs: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
UBS has maintained its Neutral rating on Universal Health Servs (NYSE:UHS) but raised its price target from $152.00 to $177.00. The stock is currently trading at $162.68, indicating a potential 8.8% increase to the new target. Universal Health Services Inc operates in the healthcare sector, focusing on acute care hospitals, behavioral health centers, and other medical facilities.

February 29, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS maintains a Neutral rating on Universal Health Servs but raises its price target from $152 to $177. The stock's current price is $162.68, suggesting an 8.8% upside potential.
The increase in the price target by UBS reflects a positive outlook on Universal Health Servs, suggesting an expectation of stock price appreciation. Given the stock is trading below the new target, there's a clear short-term upside potential. The Neutral rating indicates that while UBS sees potential for growth, it might also have some reservations, possibly due to market conditions or company-specific factors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100